ACTINIUM PHARMACEUTICALS INC's ticker is and the CUSIP is 00507W906. A total of 3 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $301 | -0.7% | 40,700 | +5.2% | 0.00% | – |
Q1 2024 | $303 | +15050.0% | 38,700 | +7640.0% | 0.00% | – |
Q4 2023 | $2 | -93.5% | 500 | -90.6% | 0.00% | – |
Q3 2023 | $31 | -70.8% | 5,300 | -63.2% | 0.00% | – |
Q2 2023 | $106 | +125.5% | 14,400 | +188.0% | 0.00% | – |
Q1 2023 | $47 | -54.4% | 5,000 | -48.5% | 0.00% | – |
Q4 2022 | $103 | -100.0% | 9,700 | -90.3% | 0.00% | -100.0% |
Q3 2022 | $738,000 | +207.5% | 100,000 | +100.4% | 0.00% | – |
Q2 2022 | $240,000 | -17.8% | 49,900 | -12.8% | 0.00% | – |
Q1 2022 | $292,000 | -26.3% | 57,200 | -13.2% | 0.00% | – |
Q4 2021 | $396,000 | -55.1% | 65,900 | -42.1% | 0.00% | -100.0% |
Q3 2021 | $881,000 | -2.1% | 113,900 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $900,000 | – | 113,900 | +15046.3% | 0.00% | – |
Q1 2021 | $0 | -100.0% | 752 | +3.6% | 0.00% | -100.0% |
Q4 2020 | $566,000 | +1921.4% | 726 | +2403.4% | 0.00% | – |
Q3 2020 | $28,000 | – | 29 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GROUP ONE TRADING, L.P. | 43,300 | $409,185 | 0.00% |
SIMPLEX TRADING, LLC | 5,000 | $47 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |